The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.

Walters, J R F; Johnston, I M; Nolan, J D; Vassie, C; Pruzanski, M E; Shapiro, D A

Walters, J R F; Johnston, I M; Nolan, J D; Vassie, C; Pruzanski, M E; Shapiro, D A.

Affiliation

Walters JR; Imperial College London & Imperial College Healthcare NHS Trust, London, UK.

Aliment Pharmacol Ther ; 41(1): 54-64, 2015 Jan.

Article in En | MEDLINE | ID: mdl-25329562

Subject(s)

Bile Acids and Salts/adverse effects; Chenodeoxycholic Acid/analogs & derivatives; Diarrhea/drug therapy; Diarrhea/etiology; Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors; Adult; Aged; Chenodeoxycholic Acid/pharmacology; Chenodeoxycholic Acid/therapeutic use; Cholestenones/antagonists & inhibitors; Diarrhea/physiopathology; Female; Fibroblast Growth Factors/biosynthesis; Humans; Ileum/metabolism; Male; Middle Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Acids and Salts / Chenodeoxycholic Acid / Receptors, Cytoplasmic and Nuclear / Diarrhea Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google